Cognition Therapeutics, Inc. CGTX
Set alert
0.71 USD +0.01 +1.63%
At close · Nov 2
0.70 -0.01 -0.92%
After hours · Nov 2, 7:34 PM ET
0.699 Day range 0.7399
0.595 52-week range 1.80
- YTD
- -47.44%
- 1 year
- -60.36%
- Open
- 0.699
- Prev close
- 0.6982
- Mkt cap
- 67.48M
- Vol
- 346.58K
- Avg vol
- 516.99K
- EPS
- -0.17
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.699
- High
- 0.7399
- Forward P/E
- -0.80
- Beta
- 1.33
- Short ratio
- 1.07
- Inst. own
- 24.53%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 0.47888
- 200-d avg
- 1.23
- 1y target
- 6.50
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 6.50 +816.0% upside
Now 0.7096
- Target (low)
- 1.50
- Target (mean)
- 6.50
- Target (high)
- 11.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.185 | -0.34 – -0.07 | -0.27 | +31.5% | 0 | 0.0% | 4 |
| Next quarter | -0.12 | -0.13 – -0.11 | -0.27 | +55.6% | 0 | 0.0% | 2 |
| Current year | -0.8525 | -1.10 – -0.62 | -0.86 | +0.9% | 0 | 0.0% | 4 |
| Next year | -0.805 | -1.71 – -0.31 | -0.8525 | +5.6% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | B. Riley Securities | Upgrade | Neutral | Buy |
| Dec 19, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Dec 19, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 6, 2024 | B. Riley Securities | Downgrade | Buy | Neutral |
| Aug 1, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 30, 2024 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jul 2, 2024 | Rodman & Renshaw | Reiterated | Buy | Buy |
| Jun 6, 2024 | Chardan Capital | Initiated | — | Buy |
| May 29, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 28, 2024 | B. Riley Securities | Reiterated | Buy | Buy |
| Mar 27, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 14, 2023 | Ladenburg Thalmann | Maintained | Buy | Buy |
| May 9, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Mar 24, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Sep 29, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| Apr 22, 2022 | Ladenburg Thalmann | Initiated | — | Buy |
| Nov 3, 2021 | Oppenheimer | Initiated | — | Outperform |